Literature DB >> 10426854

Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium.

R J Oudiz1, D E Smith, A J Pollak, I Mena, S M Shapiro, L E Ginzton, K A Narahara.   

Abstract

OBJECTIVES: This study tested the usefulness of nitrate-enhanced thallium 201 imaging for detecting myocardial viability.
BACKGROUND: Previous work suggests that nitrates enhance the ability of (201)Tl imaging to detect viable myocardium.
METHODS: Eighteen patients with coronary artery disease underwent (201)Tl imaging at rest, after 4 hours of redistribution, and during intravenous nitroglycerine infusion (mean dose = 5.96 +/- 5.37 microgram/kg/min). Twelve patients had their echocardiograms repeated after revascularization. Perfusion and wall motion were scored from 0 to 2 (absent to normal).
RESULTS: All the regions identified as viable by the rest/redistribution pair of scans were identified as viable by the rest/nitroglycerine pair of scans. Ninety-one percent of these regions were identified as viable by the single nitroglycerine scan alone. In patients who underwent revascularization, the total (201)Tl perfusion score improved from 193 to 214 after revascularization (P =.009). Wall motion score improved from 151 to 168 after revascularization (P =.09). Both the rest/nitroglycerine and rest/redistribution studies correctly predicted 14 (88%) of 16 regions that improved after revascularization. Most importantly, the rest/nitroglycerine and rest/redistribution studies were able to predict postrevascularization myocardial viability (absence of akinesis or dyskinesis after revascularization), with a sensitivity of 95% and 92%, respectively, and a predictive accuracy of 84.4%.
CONCLUSIONS: Nitroglycerine infusion during (201)Tl imaging is a useful technique for detecting underperfused, viable myocardium, requires less time to perform than rest/redistribution imaging, and may allow detection of viable myocardium with a single (201)Tl single-photon emission computed tomographic study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426854     DOI: 10.1016/s0002-8703(99)70127-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Multi-modality imaging for assessment of myocardial viability?

Authors:  Eliana Reyes
Journal:  Int J Cardiovasc Imaging       Date:  2007-06-22       Impact factor: 2.357

2.  Head-to-head comparison of contrast-enhanced cardiovascular magnetic resonance and ²⁰¹Thallium single photon emission computed tomography for prediction of reversible left ventricular dysfunction in chronic ischaemic heart disease.

Authors:  Matthias Regenfus; Christian Schlundt; Johannes von Erffa; Michaela Schmidt; Udo Reulbach; Torsten Kuwert; Werner G Daniel; Michael Schmid
Journal:  Int J Cardiovasc Imaging       Date:  2011-08-28       Impact factor: 2.357

3.  Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.

Authors:  Wei He; Wanda Acampa; Ciro Mainolfi; Francesco Menna; Anna Rita Sorrentino; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

4.  Prognostic value of nitrate enhanced Tc99m MIBI SPECT study in detecting viable myocardium in patients with coronary artery disease.

Authors:  Magdalena Kostkiewicz; Maria Olszowska; Tadeusz Przewłocki; Piotr Podolec; Wiesława Tracz
Journal:  Int J Cardiovasc Imaging       Date:  2003-04       Impact factor: 2.357

5.  Observed influence of nitroglycerine on myocardial perfusion scintigraphy in patients with multiple vessel coronary artery disease and well-developed collaterals.

Authors:  Nigora Rasulova; Lyudmila Nazirova; Khasan Akhmedov; Dilyafruz Akhmedova; Farrukh Djalalov; Amet Seydaliev; Farkhod Iskandarov; T Y Kok
Journal:  World J Nucl Med       Date:  2012-05

Review 6.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.